BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 5135408)

  • 1. Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.
    Davignon J; Aubry F; Noël C; Lapierre Y; Lafortune M
    Rev Can Biol; 1971 Dec; 30(4):307-18. PubMed ID: 5135408
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultracentrifugal demonstration of floating beta lipoproteins in type 3 hyperlipoproteinemia. Diagnostic value.
    Aubry F; Lapierre YL; Noël C; Davignon J
    Ann Intern Med; 1971 Aug; 75(2):231-7. PubMed ID: 5558651
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives.
    Patterson D; Slack J
    Lancet; 1972 Feb; 1(7747):393-9. PubMed ID: 4110639
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial hyper-pre-betalipoproteinemia with observations on the metabolism of endogenous particles.
    Rose HG
    J Lab Clin Med; 1970 Jul; 76(1):92-102. PubMed ID: 5425367
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary eruptive xanthoma. Type V hyperlipoproteinemia.
    Schreiber MM; Shapiro SI
    Arch Dermatol; 1969 Nov; 100(5):601-3. PubMed ID: 5350416
    [No Abstract]   [Full Text] [Related]  

  • 6. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):66-71. PubMed ID: 768950
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
    Hanefeld M; Schulze J; Fritz T; Kemmer C
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:160 c. PubMed ID: 4200340
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperlipoproteinemia in out-patients. Occurrence, type distribution and correlation to clinical findings].
    Wollenweber J; Christl HL; Schlierf C; Wohlenberg H
    Dtsch Med Wochenschr; 1973 Mar; 98(10):463-9. PubMed ID: 4691568
    [No Abstract]   [Full Text] [Related]  

  • 9. Essential familial hypercholesterolemia with xanthomatosis.
    Hould F; Leclerc R; Marcoux J
    Pediatrics; 1969 Mar; 43(3):455-9. PubMed ID: 5775198
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperlipoproteinaemia in gout.
    Bluestone R; Lewis B; Mervart I
    Ann Rheum Dis; 1971 Mar; 30(2):134-7. PubMed ID: 5569433
    [No Abstract]   [Full Text] [Related]  

  • 11. Bilateral parotid gland enlargement and hyperlipoproteinemia.
    Kaltreider HB; Talal N
    JAMA; 1969 Dec; 210(11):2067-70. PubMed ID: 5395209
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver scan in hyperlipoproteinemia.
    Sachs BA; Bardfeld PA; Bodian JE; Sugarman LA; Hellman L
    JAMA; 1974 Feb; 227(8):907-10. PubMed ID: 4590252
    [No Abstract]   [Full Text] [Related]  

  • 13. Musculoskeletal disorders associated with type-IV hyperlipoproteinaemia.
    Goldman JA; Glueck CJ; Abrams NR; Steiner P; Herman JH
    Lancet; 1972 Sep; 2(7775):449-52. PubMed ID: 4115343
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial hyperlipoproteinemia type 3.
    Fleischmajer R
    Arch Dermatol; 1969 Oct; 100(4):401-6. PubMed ID: 4311549
    [No Abstract]   [Full Text] [Related]  

  • 15. Familial hyperlipidemias. Diagnosis and treatment.
    Fleischmajer R; Dowlati Y; Reeves JR
    Arch Dermatol; 1974 Jul; 110(1):43-50. PubMed ID: 4371196
    [No Abstract]   [Full Text] [Related]  

  • 16. Human plasma fatty acid composition: the features of hyperlipoproteinemia and the influence of -linolenate and clofibrate.
    Takayasu K; Tada T; Okada F; Yoshikawa I
    Jpn Circ J; 1971 Sep; 35(9):1059-69. PubMed ID: 5172104
    [No Abstract]   [Full Text] [Related]  

  • 17. The biochemical, clinical, and genetic features of type III hyperlipoproteinemia.
    Morganroth J; Levy RI; Fredrickson DS
    Ann Intern Med; 1975 Feb; 82(2):158-74. PubMed ID: 163608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 4 hyperlipoproteinemia: one theory of atherogenesis.
    Zelis R; Salel AF
    Chest; 1973 Oct; 64(4):486-90. PubMed ID: 4355275
    [No Abstract]   [Full Text] [Related]  

  • 19. [The prevalence of lipid metabolism disorders in rheumatological diseases].
    Frank O; Tidl G
    Wien Med Wochenschr; 1974 Sep; 124(37):527-30. PubMed ID: 4547104
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical syndrome characteristic of primary Type IV-V hyperlipoproteinaemia.
    Borrie P; Slack J
    Br J Dermatol; 1974 Mar; 90(3):245-53. PubMed ID: 4823081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.